These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. South Dakota Medicaid will now cover OTC Loratadine and OTC Prilosec. Brandenburg V; Darger D; Christianson H; Goeden G; Engelbrecht J; Hedge D; Holm R; Ladwig W; S D J Med; 2005 Jan; 58(1):17. PubMed ID: 15696732 [No Abstract] [Full Text] [Related]
5. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines. Sullivan PW; Nichol MB Value Health; 2004; 7(4):402-12. PubMed ID: 15449632 [TBL] [Abstract][Full Text] [Related]
7. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Sullivan PW; Nair KV; Patel BV Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556 [TBL] [Abstract][Full Text] [Related]
8. FDA approves OTC Claritin. FDA Consum; 2003; 37(1):3. PubMed ID: 12625285 [No Abstract] [Full Text] [Related]
9. Pros and cons of over-the-counter availability of histamine2-receptor antagonists. Feldman M Arch Intern Med; 1993 Nov; 153(21):2415-24. PubMed ID: 8105765 [No Abstract] [Full Text] [Related]
11. Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US. Sullivan PW BMJ; 2005 Apr; 330(7496):904-5. PubMed ID: 15831881 [No Abstract] [Full Text] [Related]
12. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation. Tasch RF; Goeree R; Henke CJ; O'Brien BJ Pharmacoeconomics; 1996 Jan; 9(1):61-75. PubMed ID: 10160088 [TBL] [Abstract][Full Text] [Related]
13. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Kalish SC; Bohn RL; Avorn J Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201 [TBL] [Abstract][Full Text] [Related]
14. FDA panel recommends OTC status for second-generation antihistamines. Rollins G Ann Allergy Asthma Immunol; 2001 Jul; 87(1):3-5. PubMed ID: 11476458 [No Abstract] [Full Text] [Related]
16. Consumer usage patterns of nonprescription histamine2-receptor antagonists. Shi CW; Gralnek IM; Dulai GS; Towfigh A; Asch S Am J Gastroenterol; 2004 Apr; 99(4):606-10. PubMed ID: 15089889 [TBL] [Abstract][Full Text] [Related]
17. Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use. Hunt RH CMAJ; 1996 Jan; 154(1):49-53. PubMed ID: 8542566 [TBL] [Abstract][Full Text] [Related]